The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Heart and Ventricular Assist Devices Market Research Report 2025
Synopsis
An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) — also known as a mechanical circulatory support device — is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
The global Artificial Heart and Ventricular Assist Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Heart and Ventricular Assist Devices include SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT and Jarvik Heart Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart and Ventricular Assist Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart and Ventricular Assist Devices.
Report Scope
The Artificial Heart and Ventricular Assist Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart and Ventricular Assist Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart and Ventricular Assist Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Segment by Type
Artificial Heart
Ventricular Assist Devices
Segment by Application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart and Ventricular Assist Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart and Ventricular Assist Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) — also known as a mechanical circulatory support device — is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
The global Artificial Heart and Ventricular Assist Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Heart and Ventricular Assist Devices include SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT and Jarvik Heart Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart and Ventricular Assist Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart and Ventricular Assist Devices.
Report Scope
The Artificial Heart and Ventricular Assist Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart and Ventricular Assist Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart and Ventricular Assist Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Segment by Type
Artificial Heart
Ventricular Assist Devices
Segment by Application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart and Ventricular Assist Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart and Ventricular Assist Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Heart and Ventricular Assist Devices Market Overview
1.1 Product Overview and Scope of Artificial Heart and Ventricular Assist Devices
1.2 Artificial Heart and Ventricular Assist Devices Segment by Type
1.2.1 Global Artificial Heart and Ventricular Assist Devices Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Heart
1.2.3 Ventricular Assist Devices
1.3 Artificial Heart and Ventricular Assist Devices Segment by Application
1.3.1 Global Artificial Heart and Ventricular Assist Devices Market Value by Application: (2024-2030)
1.3.2 Coronary Heart Disease
1.3.3 Cerebrovascular Disease
1.3.4 Peripheral Arterial Disease
1.3.5 Rheumatic Heart Disease
1.3.6 Congenital Heart Disease
1.3.7 Deep Vein Thrombosis
1.3.8 Other
1.4 Global Artificial Heart and Ventricular Assist Devices Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart and Ventricular Assist Devices Revenue 2019-2030
1.4.2 Global Artificial Heart and Ventricular Assist Devices Sales 2019-2030
1.4.3 Global Artificial Heart and Ventricular Assist Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Heart and Ventricular Assist Devices Market Competition by Manufacturers
2.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Heart and Ventricular Assist Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Product Type & Application
2.7 Artificial Heart and Ventricular Assist Devices Market Competitive Situation and Trends
2.7.1 Artificial Heart and Ventricular Assist Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Heart and Ventricular Assist Devices Players Market Share by Revenue
2.7.3 Global Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario by Region
3.1 Global Artificial Heart and Ventricular Assist Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Heart and Ventricular Assist Devices Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2019-2030
3.2.1 Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2019-2024
3.2.2 Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2025-2030
3.3 Global Artificial Heart and Ventricular Assist Devices Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2019-2030
3.3.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2019-2024
3.3.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2025-2030
3.4 North America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.4.1 North America Artificial Heart and Ventricular Assist Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.4.3 North America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.5.1 Europe Artificial Heart and Ventricular Assist Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.5.3 Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Heart and Ventricular Assist Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.7.1 Latin America Artificial Heart and Ventricular Assist Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.7.3 Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Heart and Ventricular Assist Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2019-2030)
4.1.1 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2019-2024)
4.1.2 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2025-2030)
4.1.3 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2019-2030)
4.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2019-2030)
4.2.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2019-2024)
4.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2025-2030)
4.2.3 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Heart and Ventricular Assist Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2019-2030)
5.1.1 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2019-2024)
5.1.2 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2025-2030)
5.1.3 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2019-2030)
5.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2019-2030)
5.2.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2019-2024)
5.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2025-2030)
5.2.3 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Heart and Ventricular Assist Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SynCardia Systems
6.1.1 SynCardia Systems Corporation Information
6.1.2 SynCardia Systems Description and Business Overview
6.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SynCardia Systems Artificial Heart and Ventricular Assist Devices Product Portfolio
6.1.5 SynCardia Systems Recent Developments/Updates
6.2 Medtronic PLC
6.2.1 Medtronic PLC Corporation Information
6.2.2 Medtronic PLC Description and Business Overview
6.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic PLC Artificial Heart and Ventricular Assist Devices Product Portfolio
6.2.5 Medtronic PLC Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 BiVACOR
6.4.1 BiVACOR Corporation Information
6.4.2 BiVACOR Description and Business Overview
6.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BiVACOR Artificial Heart and Ventricular Assist Devices Product Portfolio
6.4.5 BiVACOR Recent Developments/Updates
6.5 Berlin Heart
6.5.1 Berlin Heart Corporation Information
6.5.2 Berlin Heart Description and Business Overview
6.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Berlin Heart Artificial Heart and Ventricular Assist Devices Product Portfolio
6.5.5 Berlin Heart Recent Developments/Updates
6.6 ABIOMED
6.6.1 ABIOMED Corporation Information
6.6.2 ABIOMED Description and Business Overview
6.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ABIOMED Artificial Heart and Ventricular Assist Devices Product Portfolio
6.6.5 ABIOMED Recent Developments/Updates
6.7 LivaNova PLC
6.6.1 LivaNova PLC Corporation Information
6.6.2 LivaNova PLC Description and Business Overview
6.6.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova PLC Artificial Heart and Ventricular Assist Devices Product Portfolio
6.7.5 LivaNova PLC Recent Developments/Updates
6.8 CARMAT
6.8.1 CARMAT Corporation Information
6.8.2 CARMAT Description and Business Overview
6.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CARMAT Artificial Heart and Ventricular Assist Devices Product Portfolio
6.8.5 CARMAT Recent Developments/Updates
6.9 Jarvik Heart Inc
6.9.1 Jarvik Heart Inc Corporation Information
6.9.2 Jarvik Heart Inc Description and Business Overview
6.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product Portfolio
6.9.5 Jarvik Heart Inc Recent Developments/Updates
6.10 Chongqing Yongrenxin Medical
6.10.1 Chongqing Yongrenxin Medical Corporation Information
6.10.2 Chongqing Yongrenxin Medical Description and Business Overview
6.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product Portfolio
6.10.5 Chongqing Yongrenxin Medical Recent Developments/Updates
6.11 Thoratec
6.11.1 Thoratec Corporation Information
6.11.2 Thoratec Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Thoratec Artificial Heart and Ventricular Assist Devices Product Portfolio
6.11.5 Thoratec Recent Developments/Updates
6.12 Cleveland Heart
6.12.1 Cleveland Heart Corporation Information
6.12.2 Cleveland Heart Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cleveland Heart Artificial Heart and Ventricular Assist Devices Product Portfolio
6.12.5 Cleveland Heart Recent Developments/Updates
6.13 CryoLife
6.13.1 CryoLife Corporation Information
6.13.2 CryoLife Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CryoLife Artificial Heart and Ventricular Assist Devices Product Portfolio
6.13.5 CryoLife Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Heart and Ventricular Assist Devices Industry Chain Analysis
7.2 Artificial Heart and Ventricular Assist Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Heart and Ventricular Assist Devices Production Mode & Process
7.4 Artificial Heart and Ventricular Assist Devices Sales and Marketing
7.4.1 Artificial Heart and Ventricular Assist Devices Sales Channels
7.4.2 Artificial Heart and Ventricular Assist Devices Distributors
7.5 Artificial Heart and Ventricular Assist Devices Customers
8 Artificial Heart and Ventricular Assist Devices Market Dynamics
8.1 Artificial Heart and Ventricular Assist Devices Industry Trends
8.2 Artificial Heart and Ventricular Assist Devices Market Drivers
8.3 Artificial Heart and Ventricular Assist Devices Market Challenges
8.4 Artificial Heart and Ventricular Assist Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Artificial Heart and Ventricular Assist Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Artificial Heart and Ventricular Assist Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Artificial Heart and Ventricular Assist Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Artificial Heart and Ventricular Assist Devices Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Artificial Heart and Ventricular Assist Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Product Type & Application
Table 12. Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Artificial Heart and Ventricular Assist Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Heart and Ventricular Assist Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Artificial Heart and Ventricular Assist Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Artificial Heart and Ventricular Assist Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2019-2024)
Table 19. Global Artificial Heart and Ventricular Assist Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2025-2030)
Table 21. Global Artificial Heart and Ventricular Assist Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Artificial Heart and Ventricular Assist Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Artificial Heart and Ventricular Assist Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Artificial Heart and Ventricular Assist Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Artificial Heart and Ventricular Assist Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Artificial Heart and Ventricular Assist Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Artificial Heart and Ventricular Assist Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Artificial Heart and Ventricular Assist Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2019-2024)
Table 53. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2025-2030)
Table 54. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Type (2019-2024)
Table 59. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Type (2025-2030)
Table 60. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2019-2024)
Table 63. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2025-2030)
Table 64. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Application (2019-2024)
Table 69. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Application (2025-2030)
Table 70. SynCardia Systems Corporation Information
Table 71. SynCardia Systems Description and Business Overview
Table 72. SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. SynCardia Systems Artificial Heart and Ventricular Assist Devices Product
Table 74. SynCardia Systems Recent Developments/Updates
Table 75. Medtronic PLC Corporation Information
Table 76. Medtronic PLC Description and Business Overview
Table 77. Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Medtronic PLC Artificial Heart and Ventricular Assist Devices Product
Table 79. Medtronic PLC Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. BiVACOR Corporation Information
Table 86. BiVACOR Description and Business Overview
Table 87. BiVACOR Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. BiVACOR Artificial Heart and Ventricular Assist Devices Product
Table 89. BiVACOR Recent Developments/Updates
Table 90. Berlin Heart Corporation Information
Table 91. Berlin Heart Description and Business Overview
Table 92. Berlin Heart Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Berlin Heart Artificial Heart and Ventricular Assist Devices Product
Table 94. Berlin Heart Recent Developments/Updates
Table 95. ABIOMED Corporation Information
Table 96. ABIOMED Description and Business Overview
Table 97. ABIOMED Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ABIOMED Artificial Heart and Ventricular Assist Devices Product
Table 99. ABIOMED Recent Developments/Updates
Table 100. LivaNova PLC Corporation Information
Table 101. LivaNova PLC Description and Business Overview
Table 102. LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. LivaNova PLC Artificial Heart and Ventricular Assist Devices Product
Table 104. LivaNova PLC Recent Developments/Updates
Table 105. CARMAT Corporation Information
Table 106. CARMAT Description and Business Overview
Table 107. CARMAT Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CARMAT Artificial Heart and Ventricular Assist Devices Product
Table 109. CARMAT Recent Developments/Updates
Table 110. Jarvik Heart Inc Corporation Information
Table 111. Jarvik Heart Inc Description and Business Overview
Table 112. Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product
Table 114. Jarvik Heart Inc Recent Developments/Updates
Table 115. Chongqing Yongrenxin Medical Corporation Information
Table 116. Chongqing Yongrenxin Medical Description and Business Overview
Table 117. Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product
Table 119. Chongqing Yongrenxin Medical Recent Developments/Updates
Table 120. Thoratec Corporation Information
Table 121. Thoratec Description and Business Overview
Table 122. Thoratec Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Thoratec Artificial Heart and Ventricular Assist Devices Product
Table 124. Thoratec Recent Developments/Updates
Table 125. Cleveland Heart Corporation Information
Table 126. Cleveland Heart Description and Business Overview
Table 127. Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Cleveland Heart Artificial Heart and Ventricular Assist Devices Product
Table 129. Cleveland Heart Recent Developments/Updates
Table 130. CryoLife Corporation Information
Table 131. CryoLife Description and Business Overview
Table 132. CryoLife Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. CryoLife Artificial Heart and Ventricular Assist Devices Product
Table 134. CryoLife Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Artificial Heart and Ventricular Assist Devices Distributors List
Table 138. Artificial Heart and Ventricular Assist Devices Customers List
Table 139. Artificial Heart and Ventricular Assist Devices Market Trends
Table 140. Artificial Heart and Ventricular Assist Devices Market Drivers
Table 141. Artificial Heart and Ventricular Assist Devices Market Challenges
Table 142. Artificial Heart and Ventricular Assist Devices Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Heart and Ventricular Assist Devices
Figure 2. Global Artificial Heart and Ventricular Assist Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Artificial Heart and Ventricular Assist Devices Market Share by Type in 2023 & 2030
Figure 4. Artificial Heart Product Picture
Figure 5. Ventricular Assist Devices Product Picture
Figure 6. Global Artificial Heart and Ventricular Assist Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Artificial Heart and Ventricular Assist Devices Market Share by Application in 2023 & 2030
Figure 8. Coronary Heart Disease
Figure 9. Cerebrovascular Disease
Figure 10. Peripheral Arterial Disease
Figure 11. Rheumatic Heart Disease
Figure 12. Congenital Heart Disease
Figure 13. Deep Vein Thrombosis
Figure 14. Other
Figure 15. Global Artificial Heart and Ventricular Assist Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Artificial Heart and Ventricular Assist Devices Market Size (2019-2030) & (US$ Million)
Figure 17. Global Artificial Heart and Ventricular Assist Devices Sales (2019-2030) & (K Units)
Figure 18. Global Artificial Heart and Ventricular Assist Devices Average Price (US$/Unit) & (2019-2030)
Figure 19. Artificial Heart and Ventricular Assist Devices Report Years Considered
Figure 20. Artificial Heart and Ventricular Assist Devices Sales Share by Manufacturers in 2023
Figure 21. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Artificial Heart and Ventricular Assist Devices Players: Market Share by Revenue in 2023
Figure 23. Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Artificial Heart and Ventricular Assist Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2019-2030)
Figure 26. North America Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2019-2030)
Figure 30. Europe Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2019-2030)
Figure 31. Germany Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region (2019-2030)
Figure 38. China Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2019-2030)
Figure 49. Latin America Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Artificial Heart and Ventricular Assist Devices by Type (2019-2030)
Figure 59. Global Revenue Market Share of Artificial Heart and Ventricular Assist Devices by Type (2019-2030)
Figure 60. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Artificial Heart and Ventricular Assist Devices by Application (2019-2030)
Figure 62. Global Revenue Market Share of Artificial Heart and Ventricular Assist Devices by Application (2019-2030)
Figure 63. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Application (2019-2030)
Figure 64. Artificial Heart and Ventricular Assist Devices Value Chain
Figure 65. Artificial Heart and Ventricular Assist Devices Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
